Exploring the anticancer potential of Jerantinine A from <i>Tabernaemontana coronaria</i> against prostate, breast, and ovarian cancers: a computational approach
These findings underscore the therapeutic potential of <i>T. coronaria</i>, particularly through Jerantinine A, as a promising candidate for cancer treatment. By targeting pivotal proteins associated with prostate, breast, and ovarian cancers, Jerantinine A offers a foundation for further research and development as a novel anti-cancer agent.
Authors
- Velliyur Kanniappan Gopalakrishnan (ORCID: https://orcid.org/0000-0002-2097-1424)
- Dhamodharan Prabhu (ORCID: https://orcid.org/0000-0003-0124-0228)
- Poornima Kannappan (ORCID: https://orcid.org/0000-0002-9685-5008)
- Manikandan Vani Raju (ORCID: https://orcid.org/0009-0005-4483-9910)
- Chella Perumal Palanisamy (ORCID: https://orcid.org/0000-0002-3527-3477)
- Raju Balaji (ORCID: https://orcid.org/0000-0003-0173-1510)
- Rathi Muthaiyan Ahalliya
- Shankari Gopalakrishnan
- Meenakshi Kaniyur Chandrasekaran
Institutions
- Karpagam Academy of Higher Education (IN)
- Saveetha University (IN)
Publication Details
- Journal
- Journal of Complementary and Integrative Medicine
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1515/jcim-2024-0443
- Citations
- 1
- Primary Topic
- Synthesis and biological activity
- Type
- article
- Field-Weighted Citation Impact
- 0.94